Exact Mass: 188.120641
Exact Mass Matches: 188.120641
Found 500 metabolites which its exact mass value is equals to given mass value 188.120641,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Azelaic acid
Nonanedioic acid is an alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate(2-) and an azelaate. Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is also produced by Malassezia furfur, also known as Pityrosporum ovale, which is a species of fungus that is normally found on human skin. Azelaic acid is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20\\\\\%. It works in part by stopping the growth of skin bacteria that cause acne, and by keeping skin pores clear. Azelaic acids antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis. Azelaic acid is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). The physiologic effect of azelaic acid is by means of Decreased Protein Synthesis, and Decreased Sebaceous Gland Activity. Azelaic Acid is a naturally occurring dicarboxylic acid produced by Malassezia furfur and found in whole grain cereals, rye, barley and animal products. Azelaic acid possesses antibacterial, keratolytic, comedolytic, and anti-oxidant activity. Azelaic acid is bactericidal against Proprionibacterium acnes and Staphylococcus epidermidis due to its inhibitory effect on the synthesis of microbial cellular proteins. Azelaic acid exerts its keratolytic and comedolytic effects by reducing the thickness of the stratum corneum and decreasing the number of keratohyalin granules by reducing the amount and distribution of filaggrin in epidermal layers. Azelaic acid also possesses a direct anti-inflammatory effect due to its scavenger activity of free oxygen radical. This drug is used topically to reduce inflammation associated with acne and rosacea. Azelaic acid is a saturated dicarboxylic acid found naturally in wheat, rye, and barley. It is a natural substance that is produced by Malassezia furfur (also known as Pityrosporum ovale), a yeast that lives on normal skin. It is effective against a number of skin conditions, such as mild to moderate acne, when applied topically in a cream formulation of 20\\\\\%. It works in part by stopping the growth of skin bacteria that cause acne, and by keeping skin pores clear. Azelaic acids antimicrobial action may be attributable to inhibition of microbial cellular protein synthesis. See also: Azelaic acid; niacinamide (component of) ... View More ... Azelaic acid (AZA) is a naturally occurring saturated nine-carbon dicarboxylic acid (COOH (CH2)7-COOH). It possesses a variety of biological actions both in vitro and in vivo. Interest in the biological activity of AZA arose originally out of studies of skin surface lipids and the pathogenesis of hypochromia in pityriasis versicolor infection. Later, it was shown that Pityrosporum can oxidize unsaturated fatty acids to C8-C12 dicarboxylic acids that are cornpetitive inhibitors of tyrosinase in vitro. Azelaic acid was chosen for further investigation and development of a new topical drug for treating hyperpigmentary disorders for the following reasons: it possesses a middle-range of antityrosinase activity, is inexpensive, and more soluble to be incorporated into a base cream than other dicarboxylic acids. Azelaic acid is another option for the topical treatment of mild to moderate inflammatory acne vulgaris. It offers effectiveness similar to that of other agents without the systemic side effects of oral antibiotics or the allergic sensitization of topical benzoyl peroxide and with less irritation than tretinoin. Azelaic acid is less expensive than certain other prescription acne preparations, but it is much more expensive than nonprescription benzoyl peroxide preparations. Whether it is safe and effective when used in combination with other agents is not known. (PMID: 7737781, 8961845). An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. Plants biology In plants, azelaic acid serves as a "distress flare" involved in defense responses after infection.[7] It serves as a signal that induces the accumulation of salicylic acid, an important component of a plant's defensive response.[8] Human biology The mechanism of action in humans is thought to be through the inhibition of hyperactive protease activity that converts cathelicidin into the antimicrobial skin peptide LL-37.[9] Polymers and related materials Esters of this dicarboxylic acid find applications in lubrication and plasticizers. In lubricant industries it is used as a thickening agent in lithium complex grease. With hexamethylenediamine, azelaic acid forms Nylon-6,9, which finds specialized uses as a plastic.[4] Medical Azelaic acid is used to treat mild to moderate acne, both comedonal acne and inflammatory acne.[10][11] It belongs to a class of medication called dicarboxylic acids. It works by killing acne bacteria that infect skin pores. It also decreases the production of keratin, which is a natural substance that promotes the growth[clarification needed] of acne bacteria.[12] Azelaic acid is also used as a topical gel treatment for rosacea, due to its ability to reduce inflammation.[11] It clears the bumps and swelling caused by rosacea. In topical pharmaceutical preparations and scientific research AzA is typically used in concentrations between 15\\\% and 20\\\% but some research demonstrates that in certain vehicle formulations the pharmaceutical effects of 10\\\% Azelaic acid has the potential to be fully comparable to that of some 20\\\% creams.[13] Acne treatment Azelaic acid is effective for mild to moderate acne when applied topically at a 15\\\%-20\\\% concentration.[14][15][16][17] In patients with moderate acne, twice daily application over 3 months of 20\\\% AzA significantly reduced the number of comedones, papules, and pustules;[18][19] at this strength, it’s considered to be as effective as benzoyl peroxide 5\\\%, tretinoin 0.05\\\%, erythromycin 2\\\%, and oral tetracycline at 500 mg-1000 mg.[20][21] In a comparative review of effects of topical AzA, Salicylic acid, Nicotinamide, Sulfur, Zinc, and alpha-hydroxy acid, AzA had more high-quality evidence of effectiveness than the rest.[22] Results can be expected after 4 weeks of twice-daily treatment. The effectiveness of long term use is unclear, but it’s been recommended that AzA be used for at least 6 months continuously for maintenance.[20] Whitening agent Azelaic acid is used for treatment of skin pigmentation, including melasma and postinflammatory hyperpigmentation, particularly in those with darker skin types. It has been recommended as an alternative to hydroquinone.[23] As a tyrosinase inhibitor,[5] azelaic acid reduces synthesis of melanin.[24] According to one report in 1988, azelaic acid in combination with zinc sulfate in vitro was found to be a potent (90\\\% inhibition) 5α-reductase inhibitor, similar to the hair loss drugs finasteride and dutasteride.[25] In vitro research during mid-1980s evaluating azelaic acid's depigmenting (whitening) capability concluded it is effective (cytotoxic to melanocytes) at only high concentrations.[26] A 1996 review claimed 20\\\% AzA is as potent as 4\\\% hydroquinone after a period of application of three months without the latter's adverse effects and even more effective if applied along with tretinoin for the same period of time.[27][19] Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2]. Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2].
Eucommiol
Eucommiol is an alicyclic compound that is cyclopent-3-en-1-ol carrying additional hydroxymethyl substituents at positions 3 and 4 as well as a 2-hydroxyethyl substituent at position 2 (the 1R,2R-diastereomer). It has a role as a sedative and a plant metabolite. It is a tetrol, a primary allylic alcohol and an alicyclic compound. Eucommiol is a natural product found in Aucuba japonica, Vitex trifolia, and other organisms with data available. An alicyclic compound that is cyclopent-3-en-1-ol carrying additional hydroxymethyl substituents at positions 3 and 4 as well as a 2-hydroxyethyl substituent at position 2 (the 1R,2R-diastereomer).
Glycylleucine
C8H16N2O3 (188.11608660000002)
Glycylleucine is a dipeptide composed of glycine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. It appears to be a common substrate for glycyl-leucine dipeptidase. A dipeptide that appears to be a common substrate for glycyl-leucine dipeptidase. [HMDB] KEIO_ID G071 Glycyl-l-leucine is a dipeptide that can be a common substrate for?glycyl-leucine?dipeptidase.
Nα-Acetyl-L-lysine
N-epsilon-Acetyl-L-lysine also known as Nepsilon-Acetyllysine or N6-Acetyllysine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at one of its nitrogen atoms. N-epsilon-Acetyl-L-lysine can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-epsilon-Acetyl-L-lysine is a biologically available sidechain, N-capped form of the proteinogenic alpha amino acid L-lysine. Unlike L-lysine, acetylated lysine derivatives such as N-epsilon-Acetyl-L-lysine are zwitterionic compounds. These are molecules that contains an equal number of positively- and negatively-charged functional groups. N-epsilon-Acetyl-L-lysine is found naturally in eukaryotes ranging from yeast to plants to humans. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins (often histones) by specific hydrolases. N-epsilon-Acetyl-L-lysine can be biosynthesized from L-lysine and acetyl-CoA via the enzyme known as Lysine N-acetyltransferase. Post-translational lysine-acetylation is one of two major modifications of lysine residues in various proteins – either N-terminal or N-alpha acetylation or N6 (sidechain) acetylation. Side-chain acetylation of specific lysine residues in the N-terminal domains of core histones is a biochemical marker of active genes. Acetylation is now known to play a major role in eukaryotic transcription. Specifically, acetyltransferase enzymes that act on particular lysine side chains of histones and other proteins are intimately involved in transcriptional activation. By modifying chromatin proteins and transcription-related factors, these acetylases are believed to regulate the transcription of many genes. The best-characterized mechanism is acetylation, catalyzed by histone acetyltransferase (HAT) enzymes. HATs function enzymatically by transferring an acetyl group from acetyl-coenzyme A (acetyl-CoA) to the amino group of certain lysine side chains within a histones basic N-terminal tail region. Within a histone octamer, these regions extend out from the associated globular domains, and in the context of a nucleosome, they are believed to bind the DNA through charge interactions (positively charged histone tails associated with negatively charged DNA) or mediate interactions between nucleosomes. Lysine acetylation, which neutralizes part of a tail regions positive charge, is postulated to weaken histone-DNA or nucleosome-nucleosome interactions and/or signal a conformational change, thereby destabilizing nucleosome structure or arrangement and giving other nuclear factors, such as the transcription complex, more access to a genetic locus. In agreement with this is the fact that acetylated chromatin has long been associated with states of transcriptional activation. Specific recognition of N6-acetyl-L-lysine is a conserved function of all bromodomains found in different proteins, recognized as an emerging intracellular signalling mechanism that plays critical roles in regulating gene transcription, cell-cycle progression, apoptosis, DNA repair, and cytoskeletal organization (PMID: 9169194 , 10827952 , 17340003 , 16247734 , 9478947 , 10839822 ). N-acetylated amino acids, such as N-epsilon-Acetyl-L-lysine can be released by an N-acylpeptide hydrolase from histones going through proteolytic degradation (PMID: 16465618). Many N-acetylamino acids are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986; PMID: 20613759). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557). Isolated from sugarbeet (Beta vulgaris) KEIO_ID A174 Nepsilon-Acetyl-L-lysine is a derivative of the amino acid lysine.
Dimethyltryptamine
An N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others.; DMT is a derivative of tryptamine with two additional methyl groups at the amine nitrogen atom. DMT is often synthesized by the Speeter-Anthony synthesis from indole using oxalyl chloride, dimethylamine, and lithium aluminium hydride as reagents. DMT is usually used in its base form, but it is more stable as a salt, e.g. as a fumarate. In contrast to DMTs base, its salts are water-soluble. DMT in solution degrades relatively fast and should be stored protected from air and light in a freezer. Highly pure DMT crystals, when evaporated out of a solvent and depositing upon glass, often produce small but highly defined white crystalline needles which when viewed under intense light will sparkle, and appear colorless under high magnification. In labs, it has been known to be explosive under a certain degree of heat.; DMT is a powerful psychoactive substance. If DMT is smoked, injected, or orally ingested with an MAOI, it can produce powerful entheogenic experiences including intense visual hallucinations, euphoria, even true hallucinations (perceived extensions of reality). A trip sitter is recommended to assist the drug user in staying physically and mentally healthy, and, in the case of smoked DMT, to catch the pipe if the user loses awareness of it.; DMT is classified in the United States as a Schedule I drug. In December of 2004, the Supreme Court lifted a stay thereby allowing the Brazil-based Uniaeo do Vegetal (UDV) church to use a decoction containing DMT in their Christmas services that year. This decoction is a tea made from boiled leaves and vines, known as hoasca within the UDV, and ayahuasca in different cultures. In Gonzales v. O Centro EspArita Beneficente Uniaeo do Vegetal, the Supreme Court heard arguments on November 1, 2005 and unanimously ruled in February 2006 that the U.S. federal government must allow the UDV to import and consume the tea for religious ceremonies under the 1993 Religious Freedom Restoration Act. There are no drug tests that would show DMT usage. None of the basic NIDA 5 drug tests or any extended drug test will show a result for DMT.; Dimethyltryptamine (DMT), also known as N,N-dimethyltryptamine, is a psychedelic tryptamine. It is not to be confused with 5-MeO-DMT and is similar in chemical structure to the neurotransmitter serotonin. DMT is created in small amounts by the human body during normal metabolism by the enzyme tryptamine-N-methyltransferase. Pure DMT at room temperature is a clear or white crystalline solid. DMT was first chemically synthesized in 1931. It also occurs naturally in many species of plants. DMT-containing plants are used in several South American shamanic practices. It is one of the main active constituents of snuffs like yopo and of the drink ayahuasca.; Oral ingestion: DMT, which is broken down by the digestive enzyme monoamine oxidase, is practically inactive if taken orally, unless combined with a monoamine oxidase inhibitor (MAOI). The traditional South American ayahuasca, or yage, is a tea mixture containing DMT and a MAOI. There are a number of admixtures to this brew, but most commonly it is simply the leaves of Psychotria viridis (containing DMT), and the vine Banisteriopsis caapi (the source of MAOI). Other DMT containing plants, including Diplopterys cabrerana, are sometimes used in ayahuasca in different areas of South America. Two common sources in the western US are Reed canary grass (Phalaris arundinacea) and Harding grass (Phalaris aquatica). These invasive grasses contain low levels of DMT and other alkaloids. Taken orally with an appropriate MAOI, DMT produces a long lasting (over 3 hour), slow, but deep spiritual experience. MAOIs should be used with extreme caution as they... Dimethyltryptamine is an N-methylated indoleamine derivative, a serotonergic hallucinogen found in several plants, especially Prestonia amazonica (Apocynaceae) and in mammalian brain, blood, and urine. It apparently acts as an agonist at some types of serotonin receptors and an antagonist at others. DMT is a derivative of tryptamine with two additional methyl groups at the amine nitrogen atom. DMT is often synthesized by the Speeter-Anthony synthesis from indole using oxalyl chloride, dimethylamine, and lithium aluminium hydride as reagents. DMT is usually used in its base form, but it is more stable as a salt, e.g. as a fumarate. In contrast to DMTs base, its salts are water-soluble. DMT in solution degrades relatively fast and should be stored protected from air and light in a freezer. Highly pure DMT crystals, when evaporated out of a solvent and depositing upon glass, often produce small but highly defined white crystalline needles which when viewed under intense light will sparkle, and appear colorless under high magnification. In labs, it has been known to be explosive under a certain degree of heat. DMT is a powerful psychoactive substance. If DMT is smoked, injected, or orally ingested with an MAOI, it can produce powerful entheogenic experiences including intense visual hallucinations, euphoria, even true hallucinations (perceived extensions of reality). A trip sitter is recommended to assist the drug user in staying physically and mentally healthy, and, in the case of smoked DMT, to catch the pipe if the user loses awareness of it. DMT is classified in the United States as a Schedule I drug. There are no drug tests that would show DMT usage. None of the basic NIDA 5 drug tests or any extended drug test will show a result for DMT. Dimethyltryptamine (DMT), also known as N,N-dimethyltryptamine, is a psychedelic tryptamine. It is not to be confused with 5-MeO-DMT and is similar in chemical structure to the neurotransmitter serotonin. DMT is created in small amounts by the human body during normal metabolism by the enzyme tryptamine-N-methyltransferase. Pure DMT at room temperature is a clear or white crystalline solid. DMT was first chemically synthesized in 1931. It also occurs naturally in many species of plants. DMT-containing plants are used in several South American shamanic practices. It is one of the main active constituents of snuffs like yopo and of the drink ayahuasca. Oral ingestion: DMT, which is broken down by the digestive enzyme monoamine oxidase, is practically inactive if taken orally, unless combined with a monoamine oxidase inhibitor (MAOI). The traditional South American ayahuasca, or yage, is a tea mixture containing DMT and a MAOI. There are a number of admixtures to this brew, but most commonly it is simply the leaves of Psychotria viridis (containing DMT), and the vine Banisteriopsis caapi (the source of MAOI). Other DMT containing plants, including Diplopterys cabrerana, are sometimes used in ayahuasca in different areas of South America. Two common sources in the western US are Reed canary grass (Phalaris arundinacea) and Harding grass (Phalaris aquatica). These invasive grasses contain low levels of DMT and other alkaloids. Taken orally with an appropriate MAOI, DMT produces a long lasting (over 3 hour), slow, but deep spiritual experience. MAOIs should be used with extreme caution as they can have lethal complications with some prescription drugs, such as SSRI antidepressants, and some over-the-counter drugs. Smoked: If DMT is smoked, the maximal effects last for a short period of time (5-30 minutes dose dependent). The onset after inhalation is very fast (less than 45 seconds) and maximal effects are reached within about a minute. The Business Mans lunch trip is a common name due to the relatively short duration of vaporized, insufflated, or injected DMT. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens
N2-acetyllysine
N-alpha-Acetyl-L-lysine also known as Nalpha-Acetyllysine, belongs to the class of organic compounds known as N-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. N-alpha-Acetyl-L-lysine can also be classified as an alpha amino acid or a derivatized alpha amino acid. Technically, N-alpha-Acetyl-L-lysine is a biologically available N-terminal capped form of the proteinogenic alpha amino acid L-lysine. Unlike L-lysine, acetylated lysine derivatives such as N-alpha-Acetyl-L-lysine are zwitterionic compounds. These are molecules that contains an equal number of positively- and negatively-charged functional groups. N-alpha-Acetyl-L-lysine is found naturally in eukaryotes ranging from yeast to plants to humans. N-acetyl amino acids can be produced either via direct synthesis of specific N-acetyltransferases or via the proteolytic degradation of N-acetylated proteins by specific hydrolases. N-terminal acetylation of proteins is a widespread and highly conserved process in eukaryotes that is involved in protection and stability of proteins (PMID: 16465618). About 85\\\% of all human proteins and 68\\\% of all yeast proteins are acetylated at their N-terminus (PMID: 21750686). Several proteins from prokaryotes and archaea are also modified by N-terminal acetylation. The majority of eukaryotic N-terminal-acetylation reactions occur through N-acetyltransferase enzymes or NAT’s (PMID: 30054468). These enzymes consist of three main oligomeric complexes NatA, NatB, and NatC, which are composed of at least a unique catalytic subunit and one unique ribosomal anchor. The substrate specificities of different NAT enzymes are mainly determined by the identities of the first two N-terminal residues of the target protein. The human NatA complex co-translationally acetylates N-termini that bear a small amino acid (A, S, T, C, and occasionally V and G) (PMID: 30054468). NatA also exists in a monomeric state and can post-translationally acetylate acidic N-termini residues (D-, E-). NatB and NatC acetylate N-terminal methionine with further specificity determined by the identity of the second amino acid. N-acetylated amino acids, such as N-alpha-Acetyl-L-lysine can be released by an N-acylpeptide hydrolase from peptides generated by proteolytic degradation (PMID: 16465618). In addition to the NAT enzymes and protein-based acetylation, N-acetylation of free lysine can also occur. In particular, N-alpha-Acetyl-L-lysine can be biosynthesized from L-lysine and acetyl-CoA via the enzyme known as Lysine N-acetyltransferase. Individuals with hyperlysinaemia due to L-lysine alpha-ketoglutarate reductase deficiency will excrete high levels of N-alpha-Acetyl-L-lysine in their urine (PMID: 116084). L-lysine alpha-ketoglutarate reductase deficiency, if untreated, can lead to neurological and behavioral deficits (PMID: 116084). Many N-acetylamino acids are classified as uremic toxins if present in high abundance in the serum or plasma (PMID: 26317986; PMID: 20613759). Uremic toxins are a diverse group of endogenously produced molecules that, if not properly cleared or eliminated by the kidneys, can cause kidney damage, cardiovascular disease and neurological deficits (PMID: 18287557). Acetyl-L-lysine is an endogenous metabolite.
Homo-L-arginine
L-homoarginine, also known as N6-(aminoiminomethyl)-L-lysine or N6-amidino-L-lysine, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. More specifically, L-homoarginine is a naturally occurring, non-proteinogenic, cationic amino acid. It is formed in the liver in a reaction catalyzed by L-arginine:glycine amidinotransferase (AGAT) when transferring the amidino group from arginine to lysine. It is an alternative substrate for nitric oxide (NO) synthase. L-homoarginine increases the availability of NO and thereby affects endothelial function. High homoarginine levels may exert positive actions that are relevant to cardiovascular health, including enhanced endothelial function, inhibition of platelet aggregation and stimulation of insulin secretion (PMID: 30866658). Recent studies have demonstrated that low serum homoarginine levels are a strong predictor of cardiovascular mortality (PMID: 24583919). L-homoarginine is a substrate of the human cationic amino acid CAT1 [solute carrier family 7 (SLC7A1)], CAT2A (SLC7A2A) or CAT2B (SLC7A2B) (PMID: 28684763). According to published human metabolomic data, L-homoarginine can be found primarily in blood, cerebrospinal fluid (CSF), and urine, as well as in human intestinal and testes tissues. Moreover, L-homoarginine has been found to be associated with liver cirrhosis and the genetic disorder, hyperargininemia. Homoarginine is an organ-specific uncompetitive inhibitor of human liver and bone alkaline phosphohydrolase (PMID: 5063678). H-HoArg-OH, a homologue arginine, is a strong inhibitor of human bone and liver alkaline phosphatase.
L-Targinine
C7H16N4O2 (188.12731960000002)
L-Targinine is found in pulses. L-Targinine is isolated from broad bean seed L-Targinine has been identified in the human placenta (PMID: 32033212). C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor D004791 - Enzyme Inhibitors
(3S)-6-Acetamido-3-aminohexanoic acid
C8H16N2O3 (188.11608660000002)
3-hydroxydecanoate
3-Hydroxycapric acid (CAS: 14292-26-3) is a normally occurring carboxylic acid in human blood plasma. Medium- and long-chain 3-hydroxymonocarboxylic acids represent intermediates in the beta-oxidation of fatty acids. They accumulate in the plasma of patients with an inherited deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35) (PMID: 1912723). 3-Hydroxyacyl-CoA dehydrogenase (HADH) deficiency has been described in diverse clinical cases: juvenile-onset recurrent myoglobinuria, hypoketotic hypoglycemic encephalopathy, hypertrophic/dilatative cardiomyopathy, sudden infant death, and fulminant hepatic failure (OMIM: 231530). 3-Hydroxycapric acid has some shape-transforming action on the membrane of intact human erythrocytes (PMID: 7318031). 3-hydroxycapric acid is a normally occurring carboxylic acid in human blood plasma. Medium- and long-chain 3-hydroxymonocarboxylic acids represent intermediates in the beta-oxidation of fatty acids. They accumulate in the plasma of patients with an inherited deficiency of long-chain 3-hydroxyacylCoA dehydrogenase [EC 1.1.1.35]. (PMID: 1912723) 3-Hydroxycapric acid is an inhibitor for mitotic progression.
Alanylvaline
C8H16N2O3 (188.11608660000002)
Alanylvaline is a dipeptide composed of alanine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Glycyl-Isoleucine
C8H16N2O3 (188.11608660000002)
Glycyl-Isoleucine is a dipeptide composed of glycine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Nonate
Nonic acid or the anion, nonate, is a derivative of succinic acid, which is a dicarboxylic acid. The anion, succinate, is a component of the citric acid cycle capable of donating electrons to the electron transfer chain. Succinate dehydrogenase (SDH) plays an important role in the mitochondria, being both part of the respiratory chain and the Krebs cycle. SDH with a covalently attached FAD prosthetic group, binds enzyme substrates (succinate and fumarate) and physiological regulators (oxaloacetate and ATP). Oxidizing succinate links SDH to the fast-cycling Krebs cycle portion where it participates in the breakdown of acetyl-CoA throughout the whole Krebs cycle. The succinate can readily be imported into the mitochondrial matrix by the n-butylmalonate- (or phenylsuccinate-) sensitive dicarboxylate carrier in exchange with inorganic phosphate or another organic acid, e. g. malate. (PMID 16143825) Mutations in the four genes encoding the subunits of the mitochondrial respiratory chain succinate dehydrogenase are associated with a wide spectrum of clinical presentations (i.e.: Huntingtons disease. (PMID 11803021) [HMDB] Nonic acid or the anion, nonate, is a derivative of succinic acid, which is a dicarboxylic acid. The anion, succinate, is a component of the citric acid cycle capable of donating electrons to the electron transfer chain. Succinate dehydrogenase (SDH) plays an important role in the mitochondria, being both part of the respiratory chain and the Krebs cycle. SDH with a covalently attached FAD prosthetic group, binds enzyme substrates (succinate and fumarate) and physiological regulators (oxaloacetate and ATP). Oxidizing succinate links SDH to the fast-cycling Krebs cycle portion where it participates in the breakdown of acetyl-CoA throughout the whole Krebs cycle. The succinate can readily be imported into the mitochondrial matrix by the n-butylmalonate- (or phenylsuccinate-) sensitive dicarboxylate carrier in exchange with inorganic phosphate or another organic acid, e. g. malate. (PMID 16143825) Mutations in the four genes encoding the subunits of the mitochondrial respiratory chain succinate dehydrogenase are associated with a wide spectrum of clinical presentations (i.e.: Huntingtons disease. (PMID 11803021).
Leucyl-Glycine
C8H16N2O3 (188.11608660000002)
Leucyl-Glycine is a dipeptide composed of leucine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
3-Methylsuberic acid
3-Methylsuberic acid belongs to the family of Branched Fatty Acids. These are fatty acids containing a branched chain.
Polycartine B
Polycartine B is a flavour enhancer. Flavour enhancer
5-Methyl-2-phenyl-2-hexenal
5-Methyl-2-phenyl-2-hexenal is found in cocoa and cocoa products. 5-Methyl-2-phenyl-2-hexenal is a constituent of various plant species and cooked foods e.g. cocoa beans and roasted peanut. 5-Methyl-2-phenyl-2-hexenal is a flavouring ingredient Constituent of various plant subspecies and cooked foods e.g. cocoa beans and roasted peanut. Flavouring ingredient. 5-Methyl-2-phenyl-2-hexenal is found in cocoa and cocoa products and nuts.
2-Hydroxydecanoate
2-Hydroxydecanoate (CAS: 5393-81-7), also known as alpha-hydroxycapric acid, is classified as a member of the medium-chain fatty acids. Medium-chain fatty acids are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. 2-Hydroxydecanoate is considered to be a practically insoluble (in water) and a weakly acidic compound. 2-Hydroxydecanoate can be found in feces.
Valylalanine
C8H16N2O3 (188.11608660000002)
Valylalanine is a dipeptide composed of valine and alanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Isoleucyl-Glycine
C8H16N2O3 (188.11608660000002)
Isoleucyl-Glycine is a dipeptide composed of isoleucine and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
cis- and trans-Ethyl 2,4-dimethyl-1,3-dioxolane-2-acetate
cis- and trans-Ethyl 2,4-dimethyl-1,3-dioxolane-2-acetate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
(+/-)-Ethyl 3-acetoxy-2-methylbutyrate
(+/-)-Ethyl 3-acetoxy-2-methylbutyrate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
(+/-)-Methyl 5-acetoxyhexanoate
(+/-)-Methyl 5-acetoxyhexanoate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
2-(3-Methylbutyl)-1H-pyrrolo[2,3-b]pyridine
2-(3-Methylbutyl)-1H-pyrrolo[2,3-b]pyridine is found in eggs. 2-(3-Methylbutyl)-1H-pyrrolo[2,3-b]pyridine is a constituent of chicken eggs. Constituent of chicken eggs. 2-(3-Methylbutyl)-1H-pyrrolo[2,3-b]pyridine is found in eggs.
Butyl ethyl malonate
Butyl ethyl malonate is a flavouring agent Flavouring agent
2-Butyl-3-phenyl-2-propen-1-al
2-Butyl-3-phenyl-2-propen-1-al is a food flavorant.
3-Buten-2-one 1-(2,3,6-trimethyl phenyl)
3-buten-2-one 1-(2,3,6-trimethyl phenyl) belongs to the family of Toluenes. These are compounds containing a benzene ring which bears a methane group.
1-H-Inden-1-one,2,3-dihydro-3,3,5,6-tetramethyl
1-H-inden-1-one,2,3-dihydro-3,3,5,6-tetramethyl belongs to the family of Indanones. These are compounds containing an indane ring bearing a ketone group.
2,4-Dimethylpimelic acid
2,4-Dimethylpimelic acid belongs to the family of Branched Fatty Acids. These are fatty acids containing a branched chain.
Diethyl methylsuccinate
Diethyl methylsuccinate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.
Diethyl glutarate
Diethyl glutarate belongs to the family of Fatty Acid Esters. These are carboxylic ester derivatives of a fatty acid.
N-(3-Amino-3-oxopropyl)-L-valine
C8H16N2O3 (188.11608660000002)
delta-N-Methylarginine
C7H16N4O2 (188.12731960000002)
Fenproporex
C78272 - Agent Affecting Nervous System > C29728 - Anorexiant
Ipidacrine
N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Methyl L-argininate
C7H16N4O2 (188.12731960000002)
N2-Methyl-L-arginine
C7H16N4O2 (188.12731960000002)
(2S)-2-Amino-5-(diaminomethylideneamino)-4-methylpentanoic acid
C7H16N4O2 (188.12731960000002)
(3Z)-4-(2,3,6-trimethylphenyl)-3-buten-2-one
Flavouring compound [Flavornet]
DIBOA tetrahexose
C8H16N2O3 (188.11608660000002)
3-(2-Hydroxyethyl)-5-(2-hydroxypropyl)-dihydrofuran-2(3H)-one
Ipidacrine
N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(2-Hydroxyethyl)-5-(2-hydroxypropyl)-4,5-dihydrofuran-2(3H)-one
(E)-1,5-Tridecadiene-7,9-diyn-4-ol|trans-Trideca-1,5-dien-7,9-diin-4-ol
2-Methylene-3-hydroperoxybutyric acid 2-methylpropyl ester
@2,3-dihydro-aethusanol-B|Dihydroaethusanol B|trideca-8t,10t-diene-4,6-diyn-1-ol
communiol C|{(3S,5S)-5-[(S)-1-hydroxypropyl]tetrahydrofuran-3-yl}acetic acid
AC-Lys-OH
C8H16N2O3 (188.11608660000002)
An acetyl-L-lysine where the acetyl group is located at the N(2)-posiiton. N-Alpha-acetyllysine is a N-acetylated amino acid. It is a normal constituent of human urine with concentrations in normal samples too small to allow its routine detection; however, it has been found at increased levels in the urine of a patient with aminoacylase I deficiency. (PMID 16274666) [HMDB] Acetyl-L-lysine is an endogenous metabolite.
Azelaic Acid
D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000970 - Antineoplastic Agents D003879 - Dermatologic Agents Annotation level-2 Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2]. Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2].
N6-acetyl-L-lysine
C8H16N2O3 (188.11608660000002)
An N(6)-acyl-L-lysine where the N(6)-acyl group is specified as acetyl. MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; DTERQYGMUDWYAZ-ZETCQYMHSA-N_STSL_0232_N-epsilon-Acetyl-L-lysine (N6)_8000fmol_190114_S2_LC02MS02_018; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. Nepsilon-Acetyl-L-lysine is a derivative of the amino acid lysine.
Homoarginine
C7H16N4O2 (188.12731960000002)
An L-lysine derivative that is the L-enantiomer of homoarginine. Homoarginine is a guanidino compounds of guanidinoethanesulfonic acid. It is an organ-specific uncompetitive inhibitor of human liver and bone alkaline phosphohydrolase. (PMID 5063678). L-Homoarginine is found in grass pea. H-HoArg-OH, a homologue arginine, is a strong inhibitor of human bone and liver alkaline phosphatase.
Glycylleucine
C8H16N2O3 (188.11608660000002)
Annotation level-3 Glycyl-l-leucine is a dipeptide that can be a common substrate for?glycyl-leucine?dipeptidase.
Ala-val
C8H16N2O3 (188.11608660000002)
A dipeptide formed from L-alanyl and L-valine residues.
Gly-ile
C8H16N2O3 (188.11608660000002)
A dipeptide formed from glycine and L-isoleucine residues.
Gly-leu
C8H16N2O3 (188.11608660000002)
A dipeptide composed of glycine and L-leucine joined by a peptide linkage.
N-Alpha-acetyllysine
C8H16N2O3 (188.11608660000002)
MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; VEYYWZRYIYDQJM-ZETCQYMHSA-N_STSL_0236_N-Alpha-acetyllysine_1000fmol_190403_S2_LC02MS02_049; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.
N,N-Dibutylthiourea
CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4283; ORIGINAL_PRECURSOR_SCAN_NO 4281 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4279; ORIGINAL_PRECURSOR_SCAN_NO 4275 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8580; ORIGINAL_PRECURSOR_SCAN_NO 8578 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8587; ORIGINAL_PRECURSOR_SCAN_NO 8585 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8610; ORIGINAL_PRECURSOR_SCAN_NO 8608 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8628; ORIGINAL_PRECURSOR_SCAN_NO 8626 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8654; ORIGINAL_PRECURSOR_SCAN_NO 8652 CONFIDENCE standard compound; INTERNAL_ID 1353; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8636; ORIGINAL_PRECURSOR_SCAN_NO 8634
azelate
Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2]. Azelaic acid is a nine-carbon dicarboxylic acid. Azelaic acid has antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermidis through inhibition of microbial cellular prorein synthesis. Azelaic acid has hypopigmentation action resulting from its ability to scavenge free radicals[1][2].
Ile-gly
C8H16N2O3 (188.11608660000002)
A dipeptide formed from L-isoleucine and glycine residues.
Leu-gly
C8H16N2O3 (188.11608660000002)
A dipeptide formed from L-leucine and glycine residues.
Val-ala
C8H16N2O3 (188.11608660000002)
A dipeptide formed from L-valine and L-alanine residues.
trimethylsilyl 3,3-dimethylbutanoate
C9H20O2Si (188.12325000000004)
1-(3-CHLOROPROPYL)-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE
N,N-dimethyl-1-(7-methyl-1H-indol-3-yl)methanamine
1H-Benzimidazole,2-(1,1-dimethylethyl)-5-methyl-(9CI)
(1S,4S)-2-(o-tolyl)-2,5-diazabicyclo[2.2.1]heptane
Acetic acid,2-[2-(1-piperazinyl)ethoxy]-
C8H16N2O3 (188.11608660000002)
Quinoxaline, 1,2,3,4-tetrahydro-2-(2-methyl-2-propenyl)- (9CI)
Quinoxaline, 1,2,3,4-tetrahydro-2-(1-methyl-2-propenyl)- (9CI)
(5-METHYL-2-PHENYL-2H-1,2,3-TRIAZOL-4-YL)METHANAMINE
((1-ETHOXY-2-METHYLPROP-1-EN-1-YL)OXY)TRIMETHYLSILANE
C9H20O2Si (188.12325000000004)
tert-butyl-(1-methoxyethenoxy)-dimethylsilane
C9H20O2Si (188.12325000000004)
2-(2-ethenylphenyl)-1,3,2-dioxaborinane
C11H13BO2 (188.10085480000004)
3-(tert-butyldimethylsilyloxy)propanal
C9H20O2Si (188.12325000000004)
Methyl-5-deoxy-2,3-O-isopropylidene-b-D-ribofuranoside
Quinoxaline, 1,2-dihydro-2-isopropyl-3-methyl- (6CI)
Quinoxaline, 1,2,3,4-tetrahydro-1,4-dimethyl-2-vinyl- (7CI)
Methyl-5-deoxy-2,3-O-isopropylidene-D-ribofuranoside
1-methyl-3-propyl-1,2-dihydroimidazol-1-ium,nitrate
Acetic acid,2-(trimethylsilyl)-, 1,1-dimethylethyl ester
C9H20O2Si (188.12325000000004)
tert-butyldimethylsilyl (r)-(-)-glycidy&
C9H20O2Si (188.12325000000004)
(3-(CYCLOPENT-1-EN-1-YL)PHENYL)BORONIC ACID
C11H13BO2 (188.10085480000004)
ethyl 2-methyl-2-trimethylsilyl-propanoate
C9H20O2Si (188.12325000000004)
tert-butyldimethylsilyl (s)-(-)-glycidy&
C9H20O2Si (188.12325000000004)
5-tert-Butyl-3,6-dihydro-2-hydrazino-1,3,4-thiadizine
(S)-2-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-PROPIONALDEHYDE
C9H20O2Si (188.12325000000004)
1-(2-methylbenzyl)-1H-1,2,4-triazol-3-amine(SALTDATA: FREE)
1H-Benzimidazole,2-methyl-1-(2-methylpropyl)-(9CI)
1H-Benzimidazole,2-methyl-1-(1-methylpropyl)-(9CI)
(R)-2-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-PROPIONALDEHYDE
C9H20O2Si (188.12325000000004)
1-((TERT-BUTYLDIMETHYLSILYL)OXY)PROPAN-2-ONE
C9H20O2Si (188.12325000000004)
butyl(3-carboxypropyl)nitrosamine
C8H16N2O3 (188.11608660000002)
D009676 - Noxae > D002273 - Carcinogens
(S)-6,6a,7,8,9,10-Hexahydro-5H-pyrido[1,2-a]quinoxaline
(R)-6,6a,7,8,9,10-Hexahydro-5H-pyrido[1,2-a]quinoxaline
[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-acetic acid
C8H16N2O3 (188.11608660000002)
tert-butyldimethylsilyl glycidyl ether
C9H20O2Si (188.12325000000004)
4-[(2,3-EPOXYPROPOXY)METHYL]-2,2-DIMETHYL-1,3-DIOXOLANE
Pentanedioic acid,2,4-dimethyl-, 1,5-dimethyl ester
2,3,4,6,7,11b-Hexahydro-1H-pyrazino[2,1-a]isoquinoline
4-AMINO-5,6,7,8-TETRAHYDRO-2H-PYRAZOLO[3,4-B]QUINOLINE
3-(tert-Butoxycarbonylamino)propanamide
C8H16N2O3 (188.11608660000002)
Hexanoic acid, trimethylsilyl ester
C9H20O2Si (188.12325000000004)
2-[(2-Amino-3-methylbutanoyl)amino]propanoic acid
C8H16N2O3 (188.11608660000002)
Pentane, 2-methyl-4-keto-2-trimethylsiloxy-
C9H20O2Si (188.12325000000004)
4-[(Trimethylsilyl)oxy]cyclohexanol
C9H20O2Si (188.12325000000004)
(9R)-9-hydroxydecanoic acid
An (omega-1)-hydroxy fatty acid that is capric acid in which the 9-pro-R hydrogen is replaced by a hydroxy group.
1-H-Inden-1-one,2,3-dihydro-3,3,5,6-tetramethyl
1-H-inden-1-one,2,3-dihydro-3,3,5,6-tetramethyl belongs to the family of Indanones. These are compounds containing an indane ring bearing a ketone group.
delta-N-Methylarginine
C7H16N4O2 (188.12731960000002)
(2S)-2-[(2-azaniumylacetyl)amino]-4-methylpentanoate
C8H16N2O3 (188.11608660000002)
3-Methylarginine
C7H16N4O2 (188.12731960000002)
A non-proteinogenic alpha-amino acid that is arginine carrying a methyl group at position 3. It is a rare amino acid produced by Pseudomonas syringae syringae, with a strong toxicity against Pseudomonas syringae glycinea, two soybean pathogens.
{[(2S)-2-azaniumyl-4-methylpentanoyl]amino}acetate
C8H16N2O3 (188.11608660000002)
(3R,6S)-6-hydroxy-3,7-dimethyloctanoic acid
An optically active form of 6-hydroxy-3,7-dimethyloctanoic acid, having (3R,6S)-configuration.
(2S)-2-Amino-5-(diaminomethylideneamino)-4-methylpentanoic acid
C7H16N4O2 (188.12731960000002)
(2S)-2-acetamido-6-ammoniohexanoate
C8H16N2O3 (188.11608660000002)
(2S)-2-ammonio-5-(N-methylcarbamimidamido)pentanoate
C7H16N4O2 (188.12731960000002)
5-methyl-L-arginine
C7H16N4O2 (188.12731960000002)
A non-proteinogenic L-alpha-amino acid that is L-arginine substituted by a methyl group at position 5.
2-Methylbutyl 2-acetyloxyacetate
An acetate ester obtained by the formal condensation of the carboxy group of (acetyloxy)acetic acid with 2-methylbutanol.
(3S,6R)-6-hydroxy-3,7-dimethyloctanoic acid
An optically active form of 6-hydroxy-3,7-dimethyloctanoic acid, having (3S,6R)-configuration.
2-Methylpentanoic acid trimethylsilyl ester
C9H20O2Si (188.12325000000004)
4-Methylvaleric acid, trimethylsilyl ester
C9H20O2Si (188.12325000000004)
(4S,5S)-4,5-Bis(methoxymethyl)-2-vinyl-1,3-dioxolane
(4S,5S)-2-Ethylidene-4,5-bis(methoxymethyl)-1,3-dioxolane
Dimethyltryptamine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens A tryptamine derivative having two N-methyl substituents on the side-chain.
H-Gly-Leu-OH
C8H16N2O3 (188.11608660000002)
Glycyl-l-leucine is a dipeptide that can be a common substrate for?glycyl-leucine?dipeptidase.
Tilarginine
C7H16N4O2 (188.12731960000002)
C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor D004791 - Enzyme Inhibitors
6-acetamido-3-aminohexanoic acid
C8H16N2O3 (188.11608660000002)
A member of the class of beta-amino acids that is the N(6)-acetyl derivative of 3,6-diaminohexanoic acid.
(S)-6-acetamido-3-aminohexanoic acid
C8H16N2O3 (188.11608660000002)
A 6-acetamido-3-aminohexanoic acid in which the chiral centre at position 3 has S-configuration.
3-Hydroxydecanoic acid
A medium-chain fatty acid that is decanoic acid substituted at position 3 by a hydroxy group. 3-Hydroxycapric acid is an inhibitor for mitotic progression.
(S)-6-acetamido-3-aminohexanoic acid zwitterion
C8H16N2O3 (188.11608660000002)
A 6-acetamido-3-aminohexanoic acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of (3S)-6-acetamido-3-aminohexanoic acid; major species at pH 7.3.
Diethyl glutarate
A diester obtained by the formal condensation of carboxy groups of glutaric acid with two molecules of ethanol respectively.
N(2)-acetyl-L-lysine zwitterion
C8H16N2O3 (188.11608660000002)
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of N(2)-acetyl-L-lysine; major species at pH 7.3.
N(5)-methyl-L-arginine
C7H16N4O2 (188.12731960000002)
A non-proteinogenic L-alpha-amino acid that is L-arginine substituted by a methyl group at N(5)-position.
procollagen 5-hydroxy-L-lysinium(1+)
Procollagen 5-hydroxy-L-lysine protonated at the 6-amino group.
N(omega)-methyl-L-arginine zwitterion
C7H16N4O2 (188.12731960000002)
The zwitterion obtained from N(omega)-methyl-L-arginine by transfer of a proton from the carboxylic acid group to the alpha-amino group.
N-isopropyl-L-glutamine
C8H16N2O3 (188.11608660000002)
A N(5)-alkylglutamine where the alkyl group is isopropyl.
glycyl-L-leucine zwitterion
C8H16N2O3 (188.11608660000002)
A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Gly-Leu. Major species at pH 7.3.
N(6)-acetyl-L-lysine zwitterion
C8H16N2O3 (188.11608660000002)
An amino acid zwitterion obtained via transfer of a proton from the carboxy to the amino group of N(6)-acetyl-L-lysine; major species at pH 7.3.
Ala-Val zwitterion
C8H16N2O3 (188.11608660000002)
A dipeptide zwitterion resulting from the transfer of a proton from the carboxy to the amino group of Ala-Val; major species at pH 7.3.
N(Omega)-methyl-L-arginine
C7H16N4O2 (188.12731960000002)
A L-arginine derivative with a N(omega)-methyl substituent.
Ile-Gly zwitterion
C8H16N2O3 (188.11608660000002)
A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Ile-Gly. Major species at pH 7.3.
Leu-Gly zwitterion
C8H16N2O3 (188.11608660000002)
A dipeptide zwitterion obtained by transfer of a proton from the carboxy to the amino terminus of Leu-Gly. Major species at pH 7.3.
N-isopropyl-L-glutamine zwitterion
C8H16N2O3 (188.11608660000002)
An amino acid zwitterion obtained by transfer of a proton from the carboxy to the amino group of N-isopropyl-L-glutamine; major species at pH 7.3.
(3R)-3-Methyl-L-arginine
C7H16N4O2 (188.12731960000002)
(2s)-6-amino-2-[(1-hydroxyethylidene)amino]hexanoic acid
C8H16N2O3 (188.11608660000002)
(1s,7s)-1-(2-hydroxyethyl)-7-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-7-ol
1-(2-hydroxyethyl)-7-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-7-ol
2,3,4,5,-trimethylphenyl-2-butene
{"Ingredient_id": "HBIN003856","Ingredient_name": "2,3,4,5,-trimethylphenyl-2-butene","Alias": "NA","Ingredient_formula": "C13H16O","Ingredient_Smile": "CC1=C(C(=C(C=C1)C=CC(=O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42896","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,4 azelaic acid
{"Ingredient_id": "HBIN004290","Ingredient_name": "2,4 azelaic acid","Alias": "NA","Ingredient_formula": "C9H16O4","Ingredient_Smile": "C(CCCC(=O)O)CCCC(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42326","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-T-butyl-5-methyl-[1,3]dioxolane-4-carboxylic acid
{"Ingredient_id": "HBIN006828","Ingredient_name": "2-T-butyl-5-methyl-[1,3]dioxolane-4-carboxylic acid","Alias": "NA","Ingredient_formula": "C9H16O4","Ingredient_Smile": "CC1C(OC(O1)C(C)(C)C)C(=O)O","Ingredient_weight": "188.22 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40849","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "582907","DrugBank_id": "NA"}
3-(2'-hydroxyethyl)-5-(2''-hydroxypropyl)-dihydrofuran-2(3h)-one
{"Ingredient_id": "HBIN007044","Ingredient_name": "3-(2'-hydroxyethyl)-5-(2''-hydroxypropyl)-dihydrofuran-2(3h)-one","Alias": "NA","Ingredient_formula": "C9H16O4","Ingredient_Smile": "CC(CC1CC(C(=O)O1)CCO)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10104","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-(3,3-dimethyl-1,4-pentadienyl)phenol
{"Ingredient_id": "HBIN009897","Ingredient_name": "4-(3,3-dimethyl-1,4-pentadienyl)phenol","Alias": "NA","Ingredient_formula": "C13H16O","Ingredient_Smile": "CC(C)(C=C)C=CC1=CC=C(C=C1)O","Ingredient_weight": "188.26 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7967","PubChem_id": "5470819","DrugBank_id": "NA"}
4,4-dimethyl-1,7-heptanedioicacid
{"Ingredient_id": "HBIN009945","Ingredient_name": "4,4-dimethyl-1,7-heptanedioicacid","Alias": "NA","Ingredient_formula": "C9H16O4","Ingredient_Smile": "CC(C)(CCC(=O)O)CCC(=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6356","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-hydroxy-10-deoxyeucommiol
{"Ingredient_id": "HBIN013197","Ingredient_name": "7-hydroxy-10-deoxyeucommiol","Alias": "NA","Ingredient_formula": "C9H16O4","Ingredient_Smile": "CC1=C(C(C(C1O)O)CCO)CO","Ingredient_weight": "188.22 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9987","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "641677","DrugBank_id": "NA"}
benzene,[1-(2-propenyloxy)-3-butenyl]
{"Ingredient_id": "HBIN017741","Ingredient_name": "benzene,[1-(2-propenyloxy)-3-butenyl]","Alias": "NA","Ingredient_formula": "C13H16O","Ingredient_Smile": "C=CCC(C1=CC=CC=C1)OCC=C","Ingredient_weight": "188.26 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40804","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "535320","DrugBank_id": "NA"}
(3r,5s)-3-(2-hydroxyethyl)-5-[(2s)-2-hydroxypropyl]oxolan-2-one
(2s)-2-amino-6-[(1-hydroxyethylidene)amino]hexanoic acid
C8H16N2O3 (188.11608660000002)
(2s,3s)-2-[(2-amino-1-hydroxyethylidene)amino]-3-methylpentanoic acid
C8H16N2O3 (188.11608660000002)
(3r,5r)-3-(2-hydroxyethyl)-5-[(2r)-2-hydroxypropyl]oxolan-2-one
(1s,4r,7r)-1-(2-hydroxyethyl)-7-(hydroxymethyl)-2-oxabicyclo[2.2.1]heptan-7-ol
2-methylpropyl (3s)-3-hydroperoxy-2-methylidenebutanoate
{[(2s,3s)-2-amino-1-hydroxy-3-methylpentylidene]amino}acetic acid
C8H16N2O3 (188.11608660000002)
3-amino-6-[(1-hydroxyethylidene)amino]hexanoic acid
C8H16N2O3 (188.11608660000002)
(2s)-2-amino-4-(isopropyl-c-hydroxycarbonimidoyl)butanoic acid
C8H16N2O3 (188.11608660000002)
(2s)-2-[(2-amino-1-hydroxyethylidene)amino]-4-methylpentanoic acid
C8H16N2O3 (188.11608660000002)
2-amino-5-carbamimidamido-3-methylpentanoic acid
C7H16N4O2 (188.12731960000002)
(2s)-2-amino-5-carbamimidamido-3-methylpentanoic acid
C7H16N4O2 (188.12731960000002)
[(3s,5s)-5-[(1s)-1-hydroxypropyl]oxolan-3-yl]acetic acid
(3s,5s)-3-(2-hydroxyethyl)-5-[(2r)-2-hydroxypropyl]oxolan-2-one
(3e,5s)-2-[(2r,3s)-3-methyloxiran-2-yl]hex-3-ene-1,2,5-triol
(1s,2r,5r)-5-(2-hydroxyethyl)-4-(hydroxymethyl)-3-methylcyclopent-3-ene-1,2-diol
(4as,9as)-2-methyl-1h,3h,4h,4ah,9h,9ah-pyrido[3,4-b]indole
6-amino-2-[(1-hydroxyethylidene)amino]hexanoic acid
C8H16N2O3 (188.11608660000002)
2-amino-4-(isopropyl-c-hydroxycarbonimidoyl)butanoic acid
C8H16N2O3 (188.11608660000002)
2-[4,5-bis(hydroxymethyl)-6-oxabicyclo[3.1.0]hexan-1-yl]ethanol
(3r,4r)-3-[(1r)-1-hydroxybutyl]-4-(hydroxymethyl)oxolan-2-one
[(3r,5r)-5-[(1s)-1-hydroxypropyl]oxolan-3-yl]acetic acid
2-[(1s,4r,5r)-4,5-bis(hydroxymethyl)-6-oxabicyclo[3.1.0]hexan-1-yl]ethanol
3-(2-hydroxyethyl)-5-(2-hydroxypropyl)oxolan-2-one
(2s)-2-amino-5-carbamimidamido-2-methylpentanoic acid
C7H16N4O2 (188.12731960000002)
(2r,3r,4r)-4-[(1e,3s)-3-hydroxybut-1-en-1-yl]-2-methyloxolane-3,4-diol
(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}propanoic acid
C8H16N2O3 (188.11608660000002)